Palisade Asset Management, LLC Dexcom Inc Transaction History

Palisade Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$114.22 - $140.1 $140,947 - $172,883	1,234 New	1,234 $171,000
Q2 2022 Aug 05, 2022	BUY	$67.99 - $132.89 $140,535 - $274,683	2,067 Added 300.0%	2,756 $205,000
Q3 2021 Oct 25, 2021	SELL	$106.71 - $143.18 $4,801 - $6,443	-45 Reduced 6.13%	689 $377,000
Q2 2021 Jul 22, 2021	SELL	$80.99 - $107.93 $24,297 - $32,379	-300 Reduced 29.01%	734 $313,000
Q1 2021 May 04, 2021	SELL	$84.79 - $104.74 $33,916 - $41,896	-400 Reduced 27.89%	1,034 $372,000
Q4 2020 Feb 03, 2021	SELL	$78.0 - $104.5 $3,198 - $4,284	-41 Reduced 2.78%	1,434 $530,000
Q1 2020 Apr 24, 2020	BUY	$47.79 - $75.63 $70,490 - $111,554	1,475 New	1,475 $397,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Palisade Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Asset Management, LLC with notifications on news.